It is a chemicals private limited company based in Yamuna Nagar, Haryana, India, established in 2017.
2017 | Yamuna Nagar, Haryana, India | ActiveLucenta Pharmaceuticals Private Limited, a active private limited company, was established on 05 April 2017 in Yamuna Nagar, Haryana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230HR2017PTC068433. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Sumit Rana (Director), Chanderpal Singh Rana (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at House No. 374 Professor Colony, Yamuna Nagar, Haryana, 135001.
U24230HR2017PTC068433
068433
05 April 2017
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Lucenta Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Rana | Director | 05 Apr 2017 | Current |
| Chanderpal Singh Rana | Director | 05 Apr 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lucenta Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 76.2% decrease. The company also saw a substantial improvement in profitability, with a 38.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 1356.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Lucenta Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lucenta Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lucenta Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucenta Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Lucenta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Lucenta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was recorded as a recent event.
Progress on Sumit Rana was appointed as a Director was appointed as a Director on 05 Apr 2017 & has been associated with this company since 8 years 8 months . was documented.
Progress on Chanderpal Singh Rana was appointed as a Director was appointed as a Director on 05 Apr 2017 & has been associated with this company since 8 years 8 months . was documented.
Progress on Lucenta Pharmaceuticals Private Limited was registered on 05 Apr 2017 with Roc Delhi & aged 8 years 8 months as per MCA records. was documented.
The CIN of Lucenta Pharmaceuticals Private Limited is U24230HR2017PTC068433.
Lucenta Pharmaceuticals Private Limited is headquartered at House No. 374 Professor Colony, Yamuna Nagar, Haryana, 135001.
Lucenta Pharmaceuticals Private Limited was incorporated on 05 April 2017.
The current directors of Lucenta Pharmaceuticals Private Limited are
The primary industry of Lucenta Pharmaceuticals Private Limited is Chemicals.
Lucenta Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lucenta Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Lucenta Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX